Cargando…
Baricitinib for the Treatment of Alopecia Areata
Alopecia areata (AA) is a relapsing, chronic, immune-mediated disease characterized by nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical presentation is heterogeneous. Its pathogenesis involves immune and genetic factors and several pro-inflammatory cytokines inv...
Autores principales: | Freitas, Egídio, Guttman-Yassky, Emma, Torres, Tiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191081/ https://www.ncbi.nlm.nih.gov/pubmed/37195491 http://dx.doi.org/10.1007/s40265-023-01873-w |
Ejemplares similares
-
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
por: Faria, Sofia, et al.
Publicado: (2023) -
The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
por: Renert-Yuval, Yael, et al.
Publicado: (2017) -
Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019) -
Efficacy and safety of baricitinib in patients with refractory alopecia areata
por: Wang, Yuqian, et al.
Publicado: (2022) -
Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
por: Elkady, Amal, et al.
Publicado: (2017)